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Abstract
Background: Recent studies have demonstrated that normal bone marrow (BM) cells transplantation can correct
liver injury in a mouse model of Wilson disease (WD). However, it still remains unknown when BM cells
transplantation should be administered. The aim of this study was to investigate the potential impact of normal
BM cells transplantation at different stages of WD to correct liver injury in toxic milk (tx) mice.
Methods: Recipient tx mice were sublethally irradiated (5 Gy) prior to transplantation. The congenic wild-type (DL)
BM cells labeled with CM-DiI were transplanted via caudal vein injection into tx mice at the early (2 months of
age) or late stage (5 months of age) of WD. The same volume of saline or tx BM cells were injected as controls.
The DL donor cell population, copper concentration, serum ceruloplasmin oxidase activity and aspartate
aminotransferase (AST) levels in the various groups were evaluated at 1, 4, 8 and 12 weeks post-transplant,
respectively.
Results: The DL BM cells population was observed from 1 to 12 weeks and peaked by the 4
th week in the
recipient liver after transplantation. DL BM cells transplantation during the early stage significantly corrected copper
accumulation, AST across the observed time points and serum ceruloplasmin oxidase activity through 8 to 12
weeks in tx mice compared with those treated with saline or tx BM cells (all P < 0.05). In contrast, BM cells
transplantation during the late stage only corrected AST levels from 4 to 12 weeks post-transplant and copper
accumulation at 12 weeks post-transplant (all P < 0.05). No significant difference was found between the saline and
tx BM cells transplantation groups across the observed time points (P > 0.05).
Conclusions: Early stage transplantation of normal BM cells is better than late stage transplantation in correcting
liver function and copper metabolism in a mouse model of WD.
Background
Wilson disease (WD) is an autosomal recessive disease
that is caused by a loss-of-function mutation in the
ATP7B gene and is characterized by hypoceruloplasmi-
nemia and excessive accumulation of copper in various
organs [1]. The accumulation of copper in turn leads to
serious chronic liver injury and neurological dysfunction
[2]. Copper chelating agents are widely used to restore
hepatic copper homeostasis, but they must be admini-
strated over a lifetime and have little effect in severe
cases. Orthotopic liver transplantation allows the recipi-
ent to metabolize copper correctly, preventing the pro-
gression of disease, and it is especially suited for
patients with liver failure [3,4]. Unfortunately, orthotopic
liver transplantation is mostly unavailable because of
several limitations such as a lack of donors, rejection
and high cost [5,6].
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plantation not only provides temporary liver function
but also cures certain metabolic conditions in the rat
model of WD [7,8]. Consistently, our previous study has
demonstrated that embryonic hepatocytes are capable of
differentiating into mature hepatocytes in vivo and par-
tially correct abnormalities of copper metabolism after
intraspleenic transplantation of homogeneous embryonic
hepatocytes in toxic milk (tx) mice [9]. However, hepa-
tocytes that are used for transplantation have to be
obtained from the limited supply of donors. Thus, it
would be highly desirable to have a readily available
alternate source of cells.
Hepatocytes can be replaced by bone marrow (BM)
cells under suitable circumstances in animals and
humans [10]. Several recent studies have demonstrated
that BM cells contribute to the renewal of hepatocytes
and have the potential to treat liver injury, including
acute or chronic liver failure [11,12]. BM cells transplan-
tation can partially reduce liver copper levels and cor-
rect liver disease in tx mice at five months post-
transplant, and the beneficial effects of BM cells trans-
plantation are similar to those obtained from normal
congenic liver cells [13]. More recently, BM cells trans-
planted into tx mice have been shown to engraft in the
liver and produce partial metabolic disease correction
via reducing liver copper and increasing ceruloplasmin
oxidase activity, although this effect may not be
sustained over a 9-month period post-transplant [14].
However, it still remains unclear when BM cells trans-
plantation should be administrated to correct liver
dysfunction in mice with WD.
The tx mouse is a naturally occurring genetic and
phenotypic model of WD derived from the congenic
wild-type (DL) mouse [15]. The tx mouse has an equiva-
lent point mutation in the ATP7B gene to humans,
which causes early copper accumulation in the liver and
late accumulation in other tissues [15,16]. Previously, we
have confirmed that tx mice present the early stage char-
acteristics of WD at 2 months of age and arrive the peak
stage of WD at 4 to 5 months of age in terms of copper
metabolism and liver function [17]. In the present study,
we aimed to further investigate whether BM cells trans-
plantation at different stages of WD has potential impli-
cations in copper metabolism and correction of liver
function in tx mice.
Methods
Mouse Strains and Animal Husbandry
The experimental protocol was approved by the local
ethical committee for animal research, and all proce-
dures involving the animals were conducted according
to institutional guidelines. DL and homologous tx mice
were kindly donated by Dr. Julian Mercer (Deakin
University, Australia) and used as BM cells donors and
recipients, respectively. All animals used in the study
were bred and maintained in the mouse facility at Sun
Yat-Sen University under 14-h light and 10-h dark
cycles. Drinking water and normal diet were regularly
maintained. Tx mice were allocated to one of the six
groups as follows: 2-month-old mice treated with DL
BM cells transplantation, 5-month-old mice treated with
DL BM cells transplantation, 2- or 5-month-old mice
treated with saline as a blank control and 2- or 5-
month-old mice treated with tx BM cells as a transplan-
tation control (40 mice per group, female:male = 3:2).
BM Cells Extraction and Transplantation
Four- to five-week-old congenic male DL mice were
selected for BM cells extraction. The femur and tibia
were flushed with D-hanks media (containing 8.00 g
NaCl, 0.40 g KCl, 0.12 g Na2HPO4·12H2O, 0.06 g
KH2PO4 and 1.00 g anhydrous dextrose in 1 L distilled
water) to extract BM cells. The cell suspension was fil-
tered through nylon mesh and centrifuged at 900 × g
for 10 min at room temperature (RT). Red blood cells
were lysed by the addition of blood cell lysis buffer
(Solarbio Company, China); a buffer volume corre-
sponding to 4 times the volume of cells was used. Tubes
were placed on ice for 15 min and then centrifuged at
450 × g for 10 min at 4°C, followed by resuspension in
D-hanks solution. To trace the donor BM cells, CM-DiI
(Molecular Probes Company,U S A )w a su s e dt ol a b e l
the BM cells. In brief, BM cells were incubated with
CM-DiI (1:250) for 5 min at RT, followed by an addi-
tional 15 min at 4°C and then centrifuged at 1500 × g
for 5 min at RT. The cells were washed with D-hanks
solution (2 x) and centrifuged at 1500 × g for 5 min at
RT. Thereafter, the cells were resuspened in D-hanks
solution to a final concentration of 6 × 10
7/ml. Before
transplantation, the number and viability of the cells
were estimated using the trypan blue exclusion test,
which was used as the standard protocol. Viable cells
accounted for 98% of the total cells. Tx BM cells were
also prepared as described above.
All recipient tx mice were sublethally irradiated (5 Gy)
three days before transplantation. To transplant cells,
animals were anesthetized with 10% chloral hydrate
(3 ml/kg body weight). Resuspended DL BM cells at a
dose of 0.2 ml were intravenously injected into 2- or
5-month-old tx mice. In saline or tx BM cells control
groups, 2- or 5-month-old tx mice received the same
volume of saline or tx BM cells instead of DL BM cells
according to the same procedures described above.
Tissue preparation
Animals were intracardiacally perfused with 0.9% saline
prior to sample collection to ensure the removal of
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from each group were sacrificed at 1, 4, 8 and 12 weeks
after transplantation for DNA extraction (n = 6 for each
time point). Genomic DNA was extracted according to
the protocol provided with the DNA extraction kit with
modification. Briefly, under deep anesthesia with 10%
chloral hydrate (5 ml/kg body weight), fresh liver tissue
was extracted from the female recipient mice and was
minced and placed in lysis buffer (50 mmol/l Tris, pH
7.5, 100 mmol/l EDTA, 100 mmol/l NaCl, 1% sodium
dodecyl sulfate containing proteinase K (0.5 mg/ml) and
incubated at 55°C overnight. The lysate was allowed to
stand at RT for 30 min to equilibrate to RT and was
then centrifuged at 4500 × g for 10 min. The superna-
tant was then placed into a filtration column and centri-
fuged at 9000 × g for 5 min. After washing to remove
contaminants, DNA was bound to the spin column
membrane by centrifugation at 9000 × g for 10 min.
The spin column was allowed to air dry for 5 min. DNA
was eluted with 200 μl TE buffer (pH 7.5) by centrifuga-
tion into a collection tube at 9000 × g for 5 min. The
purified DNA was prepared for PCR. Ten recipient mice
from each group were sacrificed at each time point for
the analysis. Blood samples were collected in heparin-
containing tubes and centrifuged at 3500 × g for 5 min
to obtain serum for ceruloplasmin oxidase activity and
aspartate aminotransferase (AST) assessment. The liver
sections from the recipient mice (10-μmt h i c k )w e r e
sectioned on a cryostat (CM1900; Leica, Heidelberger,
Nussloch, Germany) for histological evaluation or
immunohistochemistry. Additional tissues from liver,
brain and kidney were all stored for trace copper
analysis.
Polymerase Chain Reaction for Sry Gene
Donor cell repopulation was also analyzed using polymer-
ase chain reaction (PCR) amplification of the sex-deter-
mining Sry genes region in male to female transplants.
The primer sequences for the Sry genes were
5’-TGGGACTGGTGACAATTGTC-3’ (forward) and
5’-GAGTACAGGTGTGCACCTCT-3’ (reverse), with a
predicted product of 444 bp. The b-actin gene was used
as a housekeeping positive control. The primer sequences
for the b-actin genes were 5’-ATGGATGACGA-
TATCGCT-3’ (forward) and 5’-ATGAGGTAGTCTGT-
CAGG-3’ (reverse), with a predicted product of 1110 bp.
PCR was performed for 30 cycles with denaturing at 94°
C for 1 min, annealing at 55°C for 1 min and extension
at 72°C for 1 min. Engraft and cell repopulation were
expressed as ratios of the Sry genes level to the corre-
sponding b-actin genes level. The ratios of SRY to
b-actin bands were analyzed with Image pro plus imaging
analysis software.
Histopathology and Immunohistochemistry
Sections were stained with hematoxylin and eosin (HE)
for histopathological examination using standard meth-
ods and were stained with Masson’s trichrome (fibrosis-
specific staining) to evaluate the degree of liver fibrosis
as previously described [18]. The histological features
were independently assessed by 2 pathologists who were
blinded to the other details of the experiment. The CM-
DiI fluorescence intensity was monitored in the liver
sections to determine the existence of donor cells in the
recipient liver. To confirm the contribution of BM cells
to the renewal of hepatocytes, CK-18/CM-DiI double
fluorescence intensity was assessed. For immunostaining
of CK-18, sections were blocked with 3% normal horse
serum and 0.1% Triton X-100 in 0.01M PBS for 1 h at
RT. Then, the sections were incubated with mouse anti-
CK18 (1:400, Chemicon International, Temecula, CA,
USA) as the primary antibody overnight at 4°C. After
rinsing, FITC-conjugated goat anti-mouse IgG (1:400,
Jackson Immunoresearch Laboratories, USA) was
then applied for 1 h at RT. Fluorescence signals were
detected using a microscope (BX51; Olympus, Tokyo,
Japan) at excitation/emission wavelengths of 492/510
nm (FITC, green) and 550/570 nm (CM-DiI, red).
Copper Measurement
The stored liver, brain, and kidney tissues at each time
point were baked to a permanent weight and analyzed
based on atomic absorption spectrophotometry accord-
ing to the method previously described [19]. Results
were expressed in mg/kg dry weight of tissue.
Serum Ceruloplasmin Oxidase Activity and AST
Measurement
The ceruloplasmin oxidase activity in serum using o-dia-
nisidine dihydrochloride was evaluated as previously
reported [20]. The AST levels in serum were measured
using a 7170A biochemical analyzer according to stan-
dard protocols.
Statistical Analysis
Data were presented as mean ± SD. The normal distri-
bution was tested with Shapiro-Wilk test, and data were
statistically analyzed using ANOVA. Probability values
of <0.05 were considered to be statistically significant.
Results
Engraftment and repopulation after transplantation
Engraftment and repopulation of BM cells were defined
by the presence of donor DNA in female recipient tis-
sues, as characterized by the amplification of the Sry
genes. In the saline-control mice, the liver Sry genes
were undetectable at all the observed time points. Liver
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treated with male DL BM cells at 2 and 5 months of age
(Figure 1 A and 1B). The expression of the Sry gene
increased during the first week, peaked at 4 weeks and
then decreased across the observed time points after
transplantation. Furthermore, the BM cells population
in the early stage transplant group was much higher
than those in the late stage transplant group at 4 and 8
weeks after transplant (for both, P < 0.05; Figure 1C).
CK-18 was used as the specific marker for mature hepa-
tocytes. CM-DiI/CK-18 positive cells were observed in
both the sinus and parenchyma of the recipient liver as
early as the first week and lasted 12 weeks following
transplantation in tx mice (Figure 1D). A low CM-DiI
fluorescence intensity was detected in kidney and brain
(data not shown). Additionally, HE staining showed
Figure 1 Engraftment and population after bone marrow (BM) cells transplantation. The DL donor transplant cells population and
expansion were evaluated using PCR for the Sry genes in female tx mice livers in different groups. (A and B) The presence of male DL Sry
fragments was confirmed in tx mice treated with DL BM cells transplantation at 2 and 5 months of age respectively. Lane 1: saline-treated mice;
lane 2-5: tx mice at 1, 4, 8 and 12 weeks post-DL BM cells transplantation. (C) Ratios of the Sry genes to beta-actin levels were calculated in mice
treated with DL BM cells transplantation at 2 and 5 months of age at different time points (n = 6). Values were mean ± SD. Data showed a
normal distribution and were analyzed using ANOVA. *P < 0.05, compared with animals from the 5 months of age group. (D) Representative
immunofluorescent staining for CK-18 in the recipient liver showed that CM-DiI labeled donor BM cells (red) were stained positive for the
hepatocellular antigen CK-18 (green) at 4 weeks post-transplant (merged fluorescence is indicated by the arrow). Scale bar: 50 μm. (E-G) HE
staining showed the hepatic structures in saline or tx BM cells or the DL BM cells treated groups. (H-J) Masson’s trichrome staining showed no
obvious liver fibrosis in saline or tx BM cells or the DL BM cells treated groups. Scale bar: 100 μm.
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vacuoles in the nucleus in the saline and tx BM cells
control groups and the DL BM cells treated groups
(Figure 1E-G). However, liver fibrosis that was evaluated
with Masson’s trichrome staining shows no obvious
changes across the three groups (Figure 1H-J).
Effect of BM cells transplantation on the liver copper
concentration
The liver copper concentration decreased by approxi-
mately 21.2 ± 8.2% at the 1
st week, 20.3 ± 5.9% by the
4
th week, 19.7 ± 7.4% by the 8
th week and 29.7 ± 8.3%
by the 12
th week post-transplant in mice treated with
DL BM cells at 2 months of age compared to those in
age-matched mice with saline transplantation, respec-
tively (for all, P < 0.05). Consistently, DL BM cells trans-
plantation significantly reduced the liver copper
concentration at the corresponding time points post-
transplant compared to the tx BM cells control group
(for all, P < 0.05). However, despite the presence of
donor cells in mice treated with DL BM cells at 5
months of age over the observed period, the liver copper
levels decreased approximately 24.2% and 25.9% at the
12
th week after DL BM cells transplantation as com-
pared to the saline and tx BM cells control groups,
respectively (for both, P < 0.05; Figure 2A). The liver
copper concentration in mice treated with DL BM cells
transplantation at 5 months of age was not significantly
different from that in mice treated with saline or tx BM
cells at 1, 4 and 8 weeks after transplantation (for all, P
> 0.05; Figure 2B). Notably, there was some reduction in
the copper concentration in brain tissue during the 4
th
week in mice treated with DL BM cells transplantation
a t2m o n t h so fa g e( P < 0.05); however, this effect was
not evident in mice treated with DL BM cells transplan-
tation at 5 months of age. No significant differences in
the kidney copper concentrations were found between
the DL BM cells transplant group and the control
groups (P > 0.05, data not shown). Additionally, there
was no significant difference between the saline and tx
BM cells transplantation groups across the observed
time points (P > 0.05).
Effect of BM cells transplantation on the serum
ceruloplasmin oxidase activity
The serum ceruloplasmin oxidase activity in mice receiv-
ing transplantation of DL BM cells at 2 months of age
was significantly higher than that of those treated with
saline or tx BM cells from 8 to 12 weeks post-transplant,
respectively (P < 0.05, Figure 3A). However, DL BM cells
transplantation did not significantly increase the serum
ceruloplasmin oxidase activity in mice receiving trans-
plantation at 5 months of age throughout all the observed
time points as compared to those treated with saline
or tx BM cells (P > 0.05, Figure 3B). No significant
difference was found between the saline and tx BM cells
transplantation groups across the observed time points
(P > 0.05).
Effect of BM cells transplantation on the AST levels
The serum AST level was measured in different groups
to confirm the recovery of liver function. In the 2-
month-old mice transplant group, DL BM cells signifi-
cantly reduced the serum AST levels during the 1
st
week (approximately 30.4%), and the reduction persisted
for at least 12 weeks (63.0%) post-transplant as com-
pared to the saline control group at the corresponding
time points (P < 0.05, Figure 4A). Compared to the tx
BM control group, a significant reduction in the AST
levels was also found at 1 to 12 weeks post-transplant
(P < 0.05, Figure 4A). However, a significant reduction
in the AST level in mice receiving transplantation of DL
BM cells at 5 months of age was only found at 4 to
12 weeks post-transplant as compared to the saline and
Figure 2 Effect of BM cells transplantation on copper accumulation in the liver. The liver copper levels were measured by atomic
absorption spectrophotometry in recipient livers from tx mice at 1, 4, 8 and 12 weeks post-transplant. (A) Copper levels in mice treated with DL
BM cells or saline or tx BM cells transplantation at 2 months of age. (B) Copper levels in mice treated with DL BM cells or saline or tx BM cells
transplantation at 5 months of age (n = 10). Values were mean ± SD and analyzed using ANOVA. *P < 0.05, compared with the saline-treated
group; ▲P < 0.05, compared with the tx BM cells treated group.
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donor cells across the observed time points (P < 0.05,
Figure 4B). No significant difference was found between
the saline and tx BM cells transplantation groups at dif-
ferent time points (P > 0.05).
Discussion
In the present study, we have investigated the potential
effects of normal BM cells transplantation at different
stages of WD on the correction of liver function and
copper metabolism in tx mice. We found that DL BM
cells transplantation at 2 months of age corrects the
copper concentration and the AST levels in tx mice at 1
to 12 weeks post-transplant; however, these effects were
not significant in tx mice receiving DL BM cells trans-
plantation at 5 months of age. The results indicate that
early stage transplantation of BM cells has a greater
potential for the correction of liver function and copper
metabolism in mice with WD.
Recently, several studies have reported that BM cells
transplantation can partially correct liver disease in a WD
model [13,14]. Only long-term (5 or 9 months) effects of
BM cells transplantation in correcting liver injury have
been highlighted in these studies. However, the potential
effects of BM transplantation during different stages of the
disease on correcting liver function remain undetermined.
We found that the liver copper concentration and liver
function was significantly corrected at 1 to 12 weeks
following DL BM cells transplantation, indicating that nor-
mal BM cells transplantation may ameliorate liver damage
within a short period following treatment. Importantly,
early transplantation of BM cells (at 2 months of age) was
more effective for the donor cell population and liver func-
tion correction in tx mice. The underlying mechanisms
may be related to the variable selective pressure of liver
damage. Selective pressure in the form of liver injury has
been proven to be required for donor cell engraftment of
the liver [10]. However, the toxic effects of excessive
copper accumulation or an unsuitable hostile microenvir-
onment from severe liver damage have been conceived to
impede transplanted cells engraftment and the prolifera-
tion of donor cells, as indicated in the Long-Evans Cinna-
mon rat model [21-23]. Consistent with previous studies
[24], we have revealed that the accumulation of copper
Figure 3 Effect of BM cells transplantation on the ceruloplasmin oxidase activity. The serum ceruloplasmin oxidase activity was measured
using an o-dianisidine dihydrochloride test in tx mice at 1, 4, 8 and 12 weeks post-transplant. (A) Ceruloplasmin oxidase activity in mice treated
with DL BM cells or saline or tx BM cells transplantation at 2 months of age. (B) Ceruloplasmin oxidase activity in mice treated with DL BM cells
or saline or tx BM cells transplantation at 5 months of age (n = 10). Values were mean ± SD and analyzed using ANOVA. *P < 0.05, compared
with the saline-treated group; ▲P < 0.05, compared with the tx BM cells treated group.
Figure 4 Effect of BM cells transplantation on the AST levels. The serum AST levels were measured by a 7170A biochemical analyzer to
represent an index of liver function in tx mice at 1, 4, 8 and 12 weeks post-transplant. (A) Serum AST levels in mice treated with DL BM cells or
saline or tx BM cells transplantation at 2 months of age. (B) Serum AST levels in mice treated with DL BM cells or saline or tx BM cells
transplantation at 5 months of age (n = 10). Values were mean ± SD and analyzed using ANOVA. *P < 0.05, compared with the saline-treated
group; ▲P < 0.05, compared with the tx BM cells treated group.
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months of age, which is equal to 8 weeks post-transplant
in the 2-month transplant group. Then the liver copper
concentration of tx mice decreased gradually to half of the
peak concentration from 15 to 19 months of age [17]. The
control group consistently showed a reduction in the
hepatic copper concentration at 12 weeks post-transplant
in the present study. Thus, the liver microenvironment of
2-month-old tx mice was more fit for the donor cells
planting and proliferation compared to that of the
5-month-old tx mice.
Repopulation of normal BM cells in recipient livers
has been well documented in models of WD [13,14].
Based on the previous literature [25], Sry genes in Y-
chromosomes were used to verify the repopulation of
donor cells in the present study. We found that a
marked proliferation of donor BM cells occurred as
early as at the 1
st week and peaked by the 4
th week
post-transplant. Previously, donor BM cells have been
reported to significantly repopulate at the 20
th week
post-transplant with correction of liver damage in tx
mice. The major discrepancies mainly lie in the different
study designs. BM cells transplantations were performed
at 3 to 4 months, and the populations of donor cells
and liver injury rescues were generally evaluated at 5
and 9 months post-transplant in the previous studies
[13,14].
Accumulating evidence indicates that BM cells have
great differentiation plasticity and can differentiate into
many different types of tissue cells [26]. Recently, trans-
planted BM cells have been shown to repopulate as
hepatic cells under certain circumstances in liver disease
models [27,28]. To evaluate donor cells in the liver,
CM-DiI was employed as a long-term tracing marker, in
that CM-DiI has the advantages of being a photo-stable
fluorescence dye with excellent cellular retention and
minimal cytotoxicity [29-31]. We found that CM-DiI
positive donor cells appear in liver sinuses as early as
the 1
st week post-transplant and extended into liver par-
enchyma thereafter. Furthermore, some donor cells
expressed hepatocyte-related CK18 post-transplant,
suggesting the formation of hepatocyte-like cells. In
addition, there has been increasing evidence that trans-
planted marrow cells may regenerate the liver by cell
fusion [32,33]. Donor hematopoietic cells can fuse with
host hepatocytes and express both donor and host
genes, which is consistent with polyploid genome forma-
tion by the fusion of host and donor cells [33]. Interest-
ingly, CM-DiI fluorescence was present within some
hepatocytes in the current study, which suggests the
possibility of cell fusion. Therefore, transplanted BM
cells may engraft in the recipient liver and function to
improve liver injury by differentiation or cell fusion
mechanisms. However, the underlying mechanisms were
not investigated in the present study. Further studies are
needed to elucidate the cell type involved in partial dis-
ease correction and cell fusion in mice modeling WD.
Copper accumulation is common in basal ganglion and
contributes to the neurological impairment in patients
with WD. Consistent with previous studies [13,14], BM
cells transplantation, to some degree, reduced the copper
accumulation in brain tissue. However, whether lowering
copper levels can correct neurological symptoms was not
evaluated in this study because neurological symptoms
cannot be tested in tx mice [16]. Further studies are
needed to determine the potential association between
the reduction in copper accumulation and the neuron
injury following BM cells transplantation.
Conclusions
In summary, the present study suggests that normal BM
cells transplantation at an early stage of WD may be
critical for accelerating correction of liver injury in mice
with WD.
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